Veradermics/$MANE
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Veradermics
Veradermics is a dermatologist-founded, late clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut, specializing in developing therapeutics for common dermatologic conditions. Its lead candidate, VDPHL01, is an extended-release oral minoxidil tablet in Phase 3 development for treating pattern hair loss in both men and women. The company has initiated multiple Phase 3 clinical trials to support a New Drug Application submission. Veradermics has secured significant funding, including a $75 million Series B financing in December 2024 and a $150 million Series C financing in October 2025, to advance its pipeline.
Ticker
$MANE
Sector
Primary listing
NYSE
Employees
19
Headquarters
Website
Veradermics Metrics
BasicAdvanced
$500M
-
-$83.10
-
-
Price and volume
Market cap
$500M
Financial strength
Current ratio
3.286
Quick ratio
2.875
Long term debt to equity
0.122
Total debt to equity
0.122
Interest coverage (TTM)
-189.41%
Profitability
Management effectiveness
Valuation
Price to book
-0.11
Price to tangible book (TTM)
-0.11
Price to free cash flow (TTM)
-0.244
Free cash flow yield (TTM)
-409.40%
Free cash flow per share (TTM)
-69.596
Growth
Veradermics Financial Performance
Revenues and expenses
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Veradermics stock?
Veradermics (MANE) has a market cap of $500M as of February 04, 2026.
What is the P/E ratio for Veradermics stock?
The price to earnings (P/E) ratio for Veradermics (MANE) stock is 0 as of February 04, 2026.
Does Veradermics stock pay dividends?
No, Veradermics (MANE) stock does not pay dividends to its shareholders as of February 04, 2026.
When is the next Veradermics dividend payment date?
Veradermics (MANE) stock does not pay dividends to its shareholders.
What is the beta indicator for Veradermics?
Veradermics (MANE) does not currently have a Beta indicator.